Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Jun 15, 2016 $16.27 $16.27 $16.27 $16.27 134 402
Jun 14, 2016 $16.12 $16.12 $16.12 $16.12 271 130
Jun 13, 2016 $15.87 $15.87 $15.87 $15.87 220 731
Jun 10, 2016 $15.97 $15.97 $15.97 $15.97 292 351
Jun 09, 2016 $17.00 $17.00 $17.00 $17.00 143 167
Jun 08, 2016 $17.29 $17.29 $17.29 $17.29 106 915
Jun 07, 2016 $17.23 $17.23 $17.23 $17.23 124 528
Jun 06, 2016 $17.38 $17.38 $17.38 $17.38 163 256
Jun 03, 2016 $17.03 $17.03 $17.03 $17.03 161 680
Jun 02, 2016 $17.56 $17.56 $17.56 $17.56 192 709
Jun 01, 2016 $17.07 $17.07 $17.07 $17.07 166 669
May 31, 2016 $16.82 $16.82 $16.82 $16.82 139 162
May 27, 2016 $16.38 $16.38 $16.38 $16.38 148 603
May 26, 2016 $16.14 $16.14 $16.14 $16.14 96 705
May 25, 2016 $16.27 $16.27 $16.27 $16.27 147 230
May 24, 2016 $16.15 $16.15 $16.15 $16.15 166 108
May 23, 2016 $16.05 $16.05 $16.05 $16.05 150 801
May 20, 2016 $15.83 $15.83 $15.83 $15.83 195 285
May 19, 2016 $15.04 $15.04 $15.04 $15.04 191 312
May 18, 2016 $15.43 $15.43 $15.43 $15.43 275 244
May 17, 2016 $15.22 $15.22 $15.22 $15.22 240 131
May 16, 2016 $15.40 $15.40 $15.40 $15.40 353 711
May 13, 2016 $14.58 $14.58 $14.58 $14.58 211 946
May 12, 2016 $14.28 $14.28 $14.28 $14.28 237 956
May 11, 2016 $14.81 $14.81 $14.81 $14.81 350 061
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT